Statement Of Changes In Equity [Abstract]

Biofrontera AG - Filing #6520750

Concept	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-01-01	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity	—	19,980 EUR	—	—	63,807 EUR	1,000 EUR	137,330 EUR	—	181,158 EUR	—	20,336 EUR	20,336 EUR	—	—	—	180,789 EUR	63,807 EUR	0 EUR	—	137,318 EUR	—	137,332 EUR	56,717 EUR	57,426 EUR	136,623 EUR	0 EUR
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)	369,000 EUR	—	0 EUR	0 EUR	—	—	—	0 EUR	—	369,000 EUR	—	—	—	44,166 EUR	0 EUR	—	—	—	44,166 EUR	—	0 EUR	—	—	—	—	—
Other comprehensive income	1,000 EUR	—	1,000 EUR	0 EUR	—	—	—	0 EUR	—	0 EUR	—	—	0 EUR	0 EUR	0 EUR	—	—	—	0 EUR	—	0 EUR	—	—	—	—	—
Comprehensive income	368,000 EUR	—	1,000 EUR	0 EUR	—	—	—	0 EUR	—	369,000 EUR	—	—	0 EUR	44,166 EUR	0 EUR	—	—	—	44,166 EUR	—	0 EUR	—	—	—	—	—
Issue of equity	0 EUR	—	0 EUR	0 EUR	—	—	—	0 EUR	—	0 EUR	—	—	7,090 EUR	7,090 EUR	0 EUR	—	—	—	0 EUR	—	0 EUR	—	—	—	—	—
Increase (decrease) through share-based payment transactions, equity	12,000 EUR	—	0 EUR	0 EUR	—	—	—	12,000 EUR	—	0 EUR	—	—	0 EUR	50,000 EUR	50,000 EUR	—	—	—	0 EUR	—	0 EUR	—	—	—	—	—